Since CMT.64 cells do not express MHC class II molecules, a major function of CD4+ T cells may be to support CD8+ T-cell responses to tumor cells [26], [27], [28], [29], [30], [31], [32] or through a cytokine release mechanism to accumulate and activate effector cells [33]. This evidence concerns the gene CD8A and neoplasm.